首页> 外文期刊>PLoS One >A concerted probiotic activity to inhibit periodontitis-associated bacteria
【24h】

A concerted probiotic activity to inhibit periodontitis-associated bacteria

机译:齐齐异的益生菌活性,以抑制牙周炎相关的细菌

获取原文
       

摘要

Periodontitis can result in tooth loss and the associated chronic inflammation can provoke several severe systemic health risks. Adjunctive to mechanical treatment of periodontitis and as alternatives to antibiotics, the use of probiotic bacteria was suggested. In this study, the inhibitory effect of the probiotic Streptococcus salivarius subsp. salivarius strains M18 and K12, Streptococcus oralis subsp. dentisani 7746, and Lactobacillus reuteri ATCC PTA 5289 on anaerobic periodontal bacteria and Aggregatibacter actinomycetemcomitans was tested. Rarely included in other studies, we also quantified the inverse effect of pathogens on probiotic growth. Probiotics and periodontal pathogens were co-incubated anaerobically in a mixture of autoclaved saliva and brain heart infusion broth. The resulting genome numbers of the pathogens and of the probiotics were measured by quantitative real-time PCR. Mixtures of the streptococcal probiotics were also used to determine their synergistic, additive, or antagonistic effects. The overall best inhibitor of the periodontal pathogens was L . reuteri ATCC PTA 5289, but the effect is coenzyme B12-, anaerobiosis-, as well as glycerol-dependent, and further modulated by L . reuteri strain DSM 17938. Notably, in absence of glycerol, the pathogen-inhibitory effect could even turn into a growth spurt. Among the streptococci tested, S . salivarius M18 had the most constant inhibitory potential against all pathogens, followed by K12 and S . dentisani 7746, with the latter still having significant inhibitory effects on P . intermedia and A . actinomycetemcomitans . Overall, mixtures of the streptococcal probiotics did inhibit the growth of the pathogens equally or–in the case of A . actinomycetemcomitans - better than the individual strains. P . gingivalis and F . nucleatum were best inhibited by pure cultures of S . salivarius K12 or S . salivarius M18, respectively. Testing inverse effects, the growth of S . salivarius M18 was enhanced when incubated with the periodontal pathogens minus/plus other probiotics. In contrast, S . oralis subsp. dentisani 7746 was not much influenced by the pathogens. Instead, it was significantly inhibited by the presence of other streptococcal probiotics. In conclusion, despite some natural limits such as persistence, the full potential for probiotic treatment is by far not utilized yet. Especially, further exploring concerted activity by combining synergistic strains, together with the application of oral prebiotics and essential supplements and conditions, is mandatory.
机译:牙周炎可能导致牙齿损失,相关的慢性炎症可以引发几种严重的全身健康风险。建议使用促进牙周炎和抗生素替代品的辅助,提出了益生菌细菌的使用。本研究中,益生菌链球菌患者的抑制作用。唾液菌株M18和K12,链球菌Oralis Submp。测试了牙权7746和乳酸杆菌患者Reuteri ATCC PTA 5289对厌氧牙周细菌和聚合杆菌菌霉菌癌症进行了测试。很少包括在其他研究中,我们还量化了病原体对益生菌生长的倒出效应。益生菌和牙周病病原体在高压灭菌的唾液和脑心脏输注肉汤的混合物中厌氧上共培养。通过定量实时PCR测量所得病原体和益生菌的基因组数。链球菌益生菌的混合物也用于确定其协同,添加剂或拮抗作用。牙周病原体的总体最佳抑制剂是l。 Reuteri ATCC PTA 5289,但效果是辅酶B12-,厌氧症 - 以及甘油依赖性,并通过L进一步调节。 Reuteri菌株DSM 17938.特别是在没有甘油的情况下,病原体抑制作用甚至可以转化为生长刺激。在被测试的链球菌中,s。 Salivarius M18对所有病原体具有最恒定的抑制潜力,其次是K12和S. Dentisani 7746,后者仍然对p仍具有显着的抑制作用。介质和一个。辐射瘤术。总体而言,链球菌益生菌的混合物确实抑制了病原体的生长同样或 - 在a的情况下。辐射症 - 比个体菌株更好。 p。 gingivalis和f。核心由纯培养物最佳抑制。唾液K12或s。唾液M18分别。测试逆效应,S的生长。与牙周病原体减去/加上其他益生菌孵育时,Salivarius M18增强。相比之下, oralis subsp。 Dentisani 7746没有受病原体的影响。相反,通过其他链球菌益生菌的存在显着抑制。总之,尽管存在持久性等自然界,但益生菌治疗的全部潜力尚未使用。特别是,通过将协同菌株与口服益生元和必要的补充剂和条件相结合,进一步探索协同活动,是强制性的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号